Table 3 Postoperative adverse events in primary or recurrent ovarian cancer patients with ureteral reconstruction
Adverse event | Total (N = 56) | Primary (N = 35) | Recurrent (N = 21) | ||
|---|---|---|---|---|---|
Grade 1–4 | Grade 1–2 | Grade 3–4 | Grade 1–2 | Grade 3–4 | |
Ureterorenal | |||||
Ureteral anastomotic leak | 3 (5.4) | 1 (1.8) | 0 (0) | 1 (1.8) | 1 (1.8) |
Ureteral stricture | 2 (3.6) | 1 (1.8) | 0 (0) | 1 (1.8) | 0 (0) |
Urinary fistula | 3 (5.4) | 2 (3.6) | 1 (1.8) | 0 (0) | 0 (0) |
Hydronephrosis | 19 (33.9) | 8 (14.3) | 7 (12.5) | 3 (5.4) | 1 (1.8) |
Acute renal failure | 4 (7.1) | 0 (0) | 1 (1.8) | 2 (3.6) | 1 (1.8) |
Infection | |||||
Urinary tract infection | 20 (35.7) | 12 (21.4) | 3 (5.4) | 1 (1.8) | 4 (7.1) |
Wound infection | 9 (16.1) | 4 (7.1) | 2 (3.6) | 2 (3.6) | 1 (1.8) |
Sepsis | 2 (3.6) | 0 (0) | 1 (1.8) | 0 (0) | 1 (1.8) |
Respiratory | |||||
Pleural effusion | 8 (14.3) | 5 (8.9) | 0 (0) | 3 (5.4) | 0 (0) |
Pneumonia | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Cardiovascular | |||||
Thromboembolic event | 2 (3.6) | 2 (3.6) | 0 (0) | 0 (0) | 0 (0) |
Lymphocele | 17 (30.4) | 9 (16.0) | 3 (5.4) | 3 (5.4) | 2 (3.6) |